Adma Biologics (ADMA) Other Non-Current Liabilities (2011 - 2025)
Adma Biologics (ADMA) reported Other Non-Current Liabilities of $90,000 for Q3 2025, down 76.0% from $375,000 a year earlier.
Powered by 
Analysis
Adma Biologics (ADMA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
At the end of FY2024, Adma Biologics posted Other Non-Current Liabilities of $360,000, down 14.1% from FY2023.
- Other Non-Current Liabilities has a five-year compound annual growth rate of 27.6% (FY2019 to FY2024).
- By year, Other Non-Current Liabilities came in at $419,000 in FY2023 (+19.7%), $350,000 in FY2022 (-11.9%), $397,351 in FY2021 (+624.0%) and $54,886 in FY2020 (-48.5%).
- Five-year quarterly Other Non-Current Liabilities spans a low of $2,000 in Q1 2025 and a high of $768,538 in Q1 2021.
- Year over year, Other Non-Current Liabilities has now declined in each of the last six quarters, with an average decline of 34.6% over the last eight quarters.
- The high point for year-over-year Other Non-Current Liabilities in five years was Q2 2022 (growth of 934.3%); the low point was Q1 2025 (a decline of 99.5%).
- Per Business Quant data, the three quarters before Q3 2025 came in at $2,000 (Q2 2025), $2,000 (Q1 2025) and $360,000 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Adma Biologics | 2.26 Bn | 1.84 Bn | 86.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 90,000.00 |
| Jun 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | 375,000.00 |
| Jun 30, 2024 | 390,000.00 |
| Mar 31, 2024 | 405,000.00 |
| Dec 31, 2023 | 419,000.00 |
| Sep 30, 2023 | 434,647.00 |
| Jun 30, 2023 | 449,513.00 |
| Mar 31, 2023 | 338,731.00 |
| Dec 31, 2022 | 350,000.00 |
| Sep 30, 2022 | 362,179.00 |
| Jun 30, 2022 | 373,903.00 |
| Mar 31, 2022 | 385,628.00 |
| Dec 31, 2021 | 397,351.00 |
| Sep 30, 2021 | 232,665.00 |
| Jun 30, 2021 | 36,151.00 |
| Mar 31, 2021 | 768,538.00 |
| Dec 31, 2020 | 54,886.00 |
API Access
Adma Biologics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();